NEPHROS INC
For the period ended Dec 31, 2023. Filed Mar 15, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 15, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES Power of Attorney (included on the signature page). *
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| NEPHROS, INC. | |
| By: | /s/ Robert Banks |
| Name: | Robert Banks |
| Title: | President, Chief Executive Officer (Principal Executive Officer) |
| By: | /s/ Judy Krandel |
| Name: | Judy Krandel |
| Title: | Chief Financial Officer (Principal Financial and Accounting Officer) |
POWER OF ATTORNEY
We, the undersigned directors and officers of Nephros, Inc., hereby severally constitute and lawfully appoint Robert Banks, our true and lawful attorney-in-fact with full power to him to sign for us, in our names in the capacities indicated below, the Annual Report on Form 10-K for the fiscal year ended December 31, 2023 of Nephros, Inc. and any and all amendments thereto, and to file the same with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Robert Banks | President, Chief Executive Officer | March 15, 2024 |
| Robert Banks | (Principal Executive Officer) | |
| /s/ Judy Krandel | Chief Financial Officer | March 15, 2024 |
| Judy Krandel | (Principal Financial and Accounting Officer) | |
| /s/ Arthur H. Amron | Director | March 15, 2024 |
| Arthur H. Amron | ||
| /s/ Oliver Spandow | Director | March 15, 2024 |
| Oliver Spandow | ||
| /s/ Alisa Lask | Director | March 15, 2024 |
| Alisa Lask | ||
| /s/Joe Harris | Director | March 15, 2024 |
| Joe Harris | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.